期刊文献+

次黄嘌呤脱氢酶基因多态性与肾移植患者急性排斥反应的关系 被引量:5

Correlation of inosine monophosphate dehydrogenase gene polymorphisms and acute rejection in renal transplantation
原文传递
导出
摘要 目的 观察肾移植患者与霉酚酸(MPA)作用位点相关的次黄嘌呤脱氢酶(IMPDH)基因多态性对急性排斥反应的影响.方法 对105例肾移植患者采用基因测序法进行IMPDH基因多态性检测,并随访统计上述患者移植后1年内急性排斥反应的发生率,按照IMPDH不同基因型分组,分析IMPDH基因多态性与移植后1年内急性排斥反应的相关性.结果 105例患者中,所测3个位点中IMPDH1 rs2278293 GG型35例(33.33%),GA型49例(46.67%),AA型21例(20.00%);IMPDH1 rs2278294 GG型22例(20.95%),GA型49例(46.67%),AA型34例(32.38%);IMPDH2 rs11706052 GA型14例(13.33%),AA型91例(86.67%).单因素分析显示肾移植后1年内IMPDH1 rs2278293、rs2278294位点GG型患者急性排斥反应的发生率明显高于GA+AA型患者,差异有统计学意义(P<0.05).两位点联合分析显示GG-GG型患者移植后1年内急性排斥反应的发生率更高,与GA+ AA型者比较差异有统计学意义(P<0.05).结论 携带IMPDH1rs2278293、rs2278294的GA或AA型患者移植后1年内急性排斥反应发生率更低,对霉酚酸酯的治疗效果更好. Objective To investigate inosine monophosphate dehydrogenase (IMPDH) gene polymorphisms involved in mycophenolic acid (MPA) response and their association with acute rejection one year after renal transplantation.Methods We genotyped three single nucleotide polymorphisms (SNPs) in 105 Chinese Han renal transplant patients.Genotyping was performed using derect sequencing SNPs Genotyping Assays.The association of SNPs with 1-year post-transplantat acute rejection was analyzed.Results Of the 105 patients,the IMPDH1 rs2278293 genotype frequencies of GG,GA and AA were 33.33%,46.67% and 20.00% respectively.The IMPDH1 rs2278294 genotype frequencies of GG,GA and AA were 20.95%,46.67%,and 32.38% respectively.The IMPDH2 rs11706052 genotype frequencies of GA and AA were 13.33% and 86.67% respectively.The IMPDH1 rs2278293 and rs2278294 were associated with acute rejection over the first year post-transplant.Combined rs2278293 and rs2278294 genotype was associated with acute rejection one year after renal transplant.Conclusion IMPDH1 rs2278293,and rs2278294 SNPs were associated with a lower risk of acute rejection and may improve MPA treatment outcome.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2014年第12期2678-2681,共4页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(81273266) 江苏省临床医学科技专项资助项目(BL2013013、BL2014038) 江苏省医学重点学科资助项目(XK201151) 江苏省医学创新团队与领军人才资助项目(LJ201138) 苏州市科技基础设施建设计划项目(SZS201001、SZS0702)
关键词 次黄嘌呤脱氢酶 基因多态性 霉酚酸 急性排斥反应 肾移植 Inosine monophosphate dehydrogenase Gene polymorphism Mycophenolic acid Acute rejection Renal transplantation
作者简介 通信作者:何军,Email:junhe1964@163.com. 通信作者:侯建全,Email:xfl92@163.com
  • 相关文献

参考文献13

  • 1Allison AC,Eugui EM.Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection[J].Transplantation,2005,80(2 Suppl):S181-S190.
  • 2Glander P,Hambach P,Braun KP,et al.Pre-transplant inosine monophosphate dehydrogenase activity is associated with clinicad outcome after renal transplantation[J].Am J Transplant,2004,4(12):2045-2051.
  • 3Wang J,Yang JW,Zeevi A,et al.IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients[J].Clin Pharmacol Ther,2008,83(5):711-717.
  • 4孙阳洋,魏雪栋,郑浩,张辉,张江磊,侯建全,何军,邱桥成,袁晓妮.细胞色素P4503A亚家族多肽5基因多态性对肾移植患者术后他克莫司血药浓度的影响[J].中华实验外科杂志,2013,30(4):848-851. 被引量:4
  • 5Shah S,Harwood SM,Dohler B,et al.Inosine monophosphate dehydrogenase polymorphisms and renal allograft outcome[J].Transplantation,2012,94(5):486-491.
  • 6Wu TY,Peng Y,Pelleymounter LL,et al.Pharmacogenetics of the mycophenolic acid targets inosine monophosphate dehydrogenases IMPDH1 and IMPDH2:gene.sequence variation and functional genomics[J].Br J Pharmacol,2010,161(7):1584-1598.
  • 7Kagaya H,Miura M,Saito M,et al.Correlation of IMPDH1 gene polymorphisms with subclinical acute rejection and mycophenolic acid exposure parameters on day 28 after renal transplantation[J].Basic Clin Pharmacol Toxicol,2010,107(2):631-636.
  • 8Jain J,Almquist SJ,Ford PJ,et al.Regulation of inosine monophosphate dehydrogenase type Ⅰ and type Ⅱ isoforms in human lymphocytes[J].Biochem Pharmacol,2004,67(4):767-776.
  • 9Shu Q,Nair V.Inosine monophosphate dehydrogenase(IMPDH) as a target in drug discovery[J].Med Res Rev,2008,28(2):219-232.
  • 10Gensburger O,Van Schaik RH,Picard N,et al.Polymorphisms in type Ⅰ and Ⅱ inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil[J].Pharmacogenet Genomics,2010,20(9):537-543.

二级参考文献19

  • 1张雷,朱彤,郭晖,艾建华,闵志廉,朱有华,陈忠华.FTY720,40-氧-(2-羟乙基)-雷帕霉素和环孢素A延长小鼠心脏移植物存活时间的对比研究[J].中华实验外科杂志,2004,21(8):966-967. 被引量:8
  • 2张鑫,刘志红,郑敬民,陈朝红,唐政,陈劲松,黎磊石.细胞色素P450 3A5和多药耐药基因1基因多态性在肾移植患者他克莫司血药浓度监测中的应用[J].肾脏病与透析肾移植杂志,2004,13(4):313-317. 被引量:21
  • 3Naesens~ M, Kuypers DR, Sarwal M. Calcineurin Inhibitor Nephrotox- icity. Clin J Am Soc Nephrol,2009 ,4 :481-508.
  • 4Lemahieu WP, Maes BD, Verbeke K, et al. CYP3 A4 and P-glycopro- rein acfivity in healthy controls and transplant patients on cyclosporin vs. tacrolimus vs. sirolimus. Am J Transplant,2004,4:1514-1522.
  • 5Masuda S, Inui K. An up-date review on individualized dosage adjust- ment of calcineurin inhibitors in organ transplant patients, Pharmacol Ther,2006,112 : 184-198.
  • 6Krejci K, Tichy T, Bachleda P, et al. Calcineurin inhibitor-induced re-nal allograft nephrotoxicity. Biomed Pap Med Fac Univ Palacky Olo- mouc Czech Repub,2010,154:297-306.
  • 7Dai Y, Hebert MF, Isoherranen N, et al. Effect of CYP'3A5 polymor- phism on tacrolimus metabolic clearance in vitro. Drug Metab Dispos, 2006,34:836-847.
  • 8Shi Y, Li Y, Tang J, et al. Influence of CYP3A4, CYP3 A5 and MDR~I polymorphisms on tacrolimus pharmacokinetics and early renal dys- function in liver transplant recipients. Gene,2012,512:226-231.
  • 9Kuehl P, Zhang J, Lin Y,et al. Sequence diversity in CYP3 A promot- ers and characterization of the genetic basis of polymorphie CYP3A5 expression. Nat Genet,2001,27 :383-391.
  • 10Keown PA. New concepts in cyclosporine monitoring. Curt Opin Nephrol Hypertens 2002,11:619-626.

共引文献3

同被引文献34

引证文献5

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部